The long-term chronology of the association between low serum concentrations of 25-hydroxy vitamin D (25(OH)D) and weight status is unclear. We examined whether lower 25(OH)D in middle-aged women drives upwards the weight, body mass index (BMI) and waist-hip ratio (WHR) over the next 32 years, and whether higher 25(OH)D might predict less decline in the mid-to late-life height trajectory. 
INTRODUCTION
Lower serum 25-hydroxy vitamin D (25(OH)D) levels (hereafter referred to as 25D) are well known to be associated with obesity, but the direction of causality remains unclear as summarized by several recent reviews. [1] [2] [3] Because adipose tissue has nuclear vitamin D receptors and is able to synthesize the active form of vitamin D (1,25(OH)D2), it may both regulate and be regulated by 25D. 3 Possible mechanisms of how obesity could lead to lower 25D include sequestration of 25D in the adipose tissue, increased 25D catabolism (locally in adipocytes or in total body because of obesity-related inflammation), reduced exposure to sunlight or reduced 25D synthesis or activation. 3 On the other hand, low 25D could enhance adipogenesis (by several cellular-level mechanisms at various stages of the adipocyte differentiation process) or affect energy homeostasis of the adipocytes. 3, 4 We found six longitudinal observational studies on the association between 25D and measures of adiposity in adults, with follow-up time from 2 years up to slightly over a decade. [5] [6] [7] [8] [9] [10] Generally, higher baseline adiposity associated with lower 25D levels cross-sectionally and longitudinally; 5, 7 and with increased incidence of 25D deficiency in one study, 5 but not in another. 9 Exploring the effect of baseline 25D on the onset of obesity, lower 25D associated with a higher incidence of obesity during 4-11 years of follow-up, 8, 9 but this was not confirmed in a study with 5-year follow-up. 10 Jorde et al. 6 found that an increase in BMI was accompanied by 25D decrease and conversely a decrease in BMI by 25D increase during 14 years of follow-up. The variation in these findings may be (partly) explained by different measures of adiposity, continuous vs categorized exposures and outcomes, varying definitions of 25D deficiency and follow-up times as well as analytical approaches.
Our primary aim was to evaluate the association between serum 25D in middle-aged women and their adiposity trajectories during three decades of follow-up. We used weight and body mass index (BMI) as indicators of overall adiposity, and waist-hip ratio (WHR) for central adiposity. We hypothesized that lower 25D drives the adiposity trajectory upwards. Our secondary aim was to assess the association of 25D to the height trajectory, for two main reasons. First, as BMI depends on weight and height, changes in the BMI trajectory could also be driven by changes in height. Moreover, 25D could theoretically 11, 12 protect from the well-known height loss in older age. 13 Therefore, our second hypothesis was that higher 25D is associated with less decline in the mid-to late-life height trajectory.
SUBJECTS AND METHODS
The present study is part of the Population Study of Women in Gothenburg, Sweden. In 1968, women born in 1908, 1914, 1918, 1922 and 1930 were systematically sampled from the census register based on specific birthdates in order to yield a representative cohort of 38-, 46-, 50-, 54-and 60-year-old women. Of those sampled, 1462 women (participation rate 90%) attended a health examination in 1968-1969. 14 This examination constituted the baseline for a prospective study with four re-examinations in 1974-1975, 1981-1982, 1992-1993 and 2000-2003 . Of the original sample, 661 women participated in the re-examination in 2000-2003 (71% of those alive at that time). Details of the sampling, participation rates and data collection protocol have been described earlier. [14] [15] [16] [17] [18] The Ethics Committee of the University of Gothenburg approved the study. All subjects gave informed consent to participate, according to the provisions of the Helsinki Declaration.
During the baseline visit, a fasting blood sample (120 ml) was drawn from each participant. A small quantity was used for immediate analysis and the remainder was stored for future analyses as follows. The sample was first allowed to clot at room temperature and then centrifuged. Then, the serum was divided in 2.5 ml covered polystyrene cups enclosed together in small batches in firmly tied plastic bags that were then stored at − 20°C. In 2013, the serum samples were retrieved from the storage, and 25D levels were analyzed with the Cobas e601 instrument that uses the Roche Diagnostics (Penzberg, Germany) 25D total assay and a competitive electrochemiluminescence immunoassay protein-binding assay. The assay employs a 25D binding protein as a capture protein that binds to both 25D 3 and 25D 2 . Intra-and inter-assay coefficients of variation were below 5%. The analysis was performed at the Clinical Chemistry Laboratory, Sahlgrenska University Hospital, Mölndal (Gothenburg, Sweden). 19 Among the 1462 participants of the 1968-1969 examination, 25D was measured for 1227 women (84% of the participants; Figure 1 ).
All anthropometric measures were taken with the woman standing and wearing only briefs. 14, 20 Weight was measured to the nearest 0.1 kg with a balance scale. Height without shoes was measured to the nearest 0.5 cm. Waist circumference was measured to the nearest 1 mm at the level midway between the lower rib margin and the iliac crest using a steel tape measure. Hip circumference was measured with the same tape measure to the nearest 1 mm at the widest point between hip and buttock. BMI (unit kg/m 2 ) and WHR were calculated. In the present study, BMI was used as an indicator of overall adiposity, and WHR of central adiposity. In 1968-1969, weight and height were available for all the 1227 women with measured 25D and WHR for 1211 women, respectively. In 2000-2003, the respective figures were 486 for weight and height, and 484 for WHR (Figure 1 ).
Information about education and occupational class (OC; based on the woman's or her husband's profession, whichever was highest between them) was obtained through questionnaires. Information about smoking habits and smoking history, as well as physical activity during leisure time (LTPA) was obtained via standardized interviews 14 at each examination. Age at the menopause was obtained from a questionnaire supplemented by an interview at each follow-up examination; this was used in the present study to determine whether the woman had reached menopause by the time of the examination in question. Country of origin was defined based on information about the birth place obtained from the Revenue Office Register. The categories of the background factors as used in the present study are shown in Table 1 . Finally, season of the baseline 25D measurement was defined as early summer (May-June), late summer (August-October) or winter (November-April).
Statistical methods
Means and s.d. were calculated for 25D, height, weight, BMI and WHR. Differences in mean values of 25D, height, weight, BMI and WHR according to different baseline background factors were tested with analysis of variance (two sided). For the purpose of further analyses, 25D values were dichotomized into the lowest quartile (51.45 nmol/l) versus the upper three quartiles combined. At each study visit, differences in mean values of the anthropometric measures between the two categories of baseline 25D were tested with analysis of variance.
Cross-sectional associations between 25D and anthropometric measures at baseline were modeled using linear regression. In these models, each of the baseline anthropometric measures (height, weight, BMI, WHR: dependent variables) in turn was examined in relation to baseline 25D (main independent variable). Adjustment for potential confounders (age, educational level, OC, country of origin, smoking, LTPA, menopause and season of 25D measurement) was first done using a stepwise regression. Then, each variable left out from the stepwise regression was re-entered into the model, in order to see how much it would change the estimate for 25D.
General linear modeling (GLM) was used to analyze associations between baseline 25D (main independent variable) and repeated measures of height, weight, BMI and WHR (dependent variables). Two kinds of models were fitted for each of these anthropometric measures: model 1 was for examining the association between baseline 25D and the average time trend across all visits, and to compare this with the crosssectional baseline association. In model 1, the baseline anthropometric measure was one of the repeated measures. Model 2 was for evaluating whether there was any difference between 25D categories in the anthropometric trend once the baseline difference was taken into account. Here, the repeated measurements model included only the re-examinations, while adjusting for the baseline anthropometric measure. In both models, the other baseline covariates were added in one by one. Finally, further adjusted models included smoking, menopause and LTPA as timevarying covariates. The equation for the final model for BMI is as follows:
where BMIij denotes BMI for individual i at follow-up visit j; j = 1,…4, β 1 denotes the effect of baseline BMI (BMI 0 ) and β 2 is the expected effect of follow-up visit j, OC denotes occupational class and LTPA denotes leisure-time physical activity. An unstructured covariance matrix was used for this model. Four types of additional analyses were done. (1) The potential confounding and modifying effects of OC on the association between 25D and development of height and adiposity indicators were assessed by stratifying by OC, and by including an interaction term between OC and 25D into the regression model. For these analyses, OC was dichotomized into higher (higher employee and employee) and lower (worker) OC. ( 2) The risk of overweight including obesity in relation to 25D was tested through the relative risk using a log-binomial regression model (Proc GENMOD) that controlled for age, season, menopause and education (stepwise selection of potential confounders). Overweight was defined as BMI ⩾ 25 kg/m 2 at any of the re-examinations. This analysis included only subjects with a normal baseline BMI (BMI o25 kg/m 2 ) and a valid BMI assessment for at least one of the re-examinations. (3) Drop-out analyses at each re-examination compared participants and surviving nonparticipants with regard to their baseline mean 25D and mean adiposity indicators in general linear modeling models that adjusted for age (where necessary). Risk of nonparticipation was modeled in relation to baseline characteristics Figure 1 . Flow chart of the study participants of the Population Study of Women in Gothenburg, Sweden.
Vitamin D, adiposity and height over three decades S Lehtinen-Jacks et al in logistic regression models adjusted for age. (4) The potential effect of different 25D cut points on the results was evaluated by a reanalysis of the association between baseline 25D and repeatedly measured BMI, where both the lowest (⩽51.45 nmol/l) and the highest (489.31 nmol/l) quarter of baseline 25D were compared with the two middle quarters combined. The β-coefficients and 95% confidence intervals are reported for all regression analyses, as well as R 2 values for the cross-sectional models. For all statistical tests, the assumptions were verified. All statistical analyses were conducted with SAS 9.2 (SAS Institute Inc., Cary, NC, USA).
RESULTS
Women with 25D measured in August through October had the highest mean 25D and lowest WHR, whereas women whose 25D was measured in May-June had the lowest 25D and highest WHR (Table 1) . Women with lower education, OC or less LTPA had lower 25D, as did postmenopausal women. Women of non-Swedish origin had nonsignificantly lower 25D. At baseline, older and postmenopausal women were significantly shorter and had higher adiposity. Similarly, women with lower education, OC or LTPA had higher adiposity. Lower education was associated with shorter height. Prevalence of overweight was lowest among smokers. Women of non-Swedish origin were somewhat shorter than other women ( Table 1) .
The women who were lost to follow-up were more likely to have lower 25D, higher baseline BMI, weight and WHR than those who came for re-examination. Lower education, having reached Vitamin D, adiposity and height over three decades S Lehtinen-Jacks et al menopause at baseline, smoking and being examined during early summer were also associated with higher attrition. Mean weight was higher at baseline in women with lower 25D (67.5 vs 63.7 kg, P o0.001), as well as at all subsequent study visits (nonsignificant at the third re-examination) (Figure 2 ). When adjusting for covariates, the baseline association was unchanged, with 4.15 kg higher weight for women with lower 25D (Table 2 ; R 2 25.0%). In the longitudinal analyses, adjusted for covariates, there was little change in the estimate of 25D when all visits were included compared with the baseline association; however, when considering only the re-examinations adjusted for baseline weight, the association became negligible (Table 2 ). These conclusions remained unchanged for high and low OC categories.
Similar to weight, BMI was higher at baseline in women with lower 25D (25.2 vs 23.8 kg/m 2 , P o0.001), as well as at all subsequent study visits (nonsignificant at the third re-examination) (Figure 2 ). When adjusting for covariates, the baseline association was unchanged, with 1.51 kg/m 2 higher BMI for women with lower 25D (Table 2 , R 2 14.1%); especially in women in the low OC ( Table 2 ). In the repeated measurement models, adjusted for covariates, the estimate of 25D on BMI remained similar to the baseline estimate when all visits were included, but became negligible when only re-examinations were included with adjustment for baseline BMI ( Table 2 ). The same was observed for stratified groups with high and low OC. The additional analysis with a three-category 25D variable showed that women with high 25D (highest quarter, 489.31 nmol/l) at baseline had lower BMI at baseline and thereafter, and thus confirmed the main longitudinal results (data not shown).
Mean WHR was also higher in women with lower 25D at baseline (0.75 vs 0.74, Po0.001) and at the two first re-examinations ( Figure 2 ). The baseline association was unchanged when adjusting for covariates: WHR was 0.013 higher for women with lower 25D (Table 2 ; R 2 11.8%). Similar to weight and BMI, lower 25D was associated with higher WHR longitudinally when all visits were included but not when baseline WHR was taken into account in the repeated measures model ( Table 2 ). The estimate of 25D on WHR was negligible in women with higher and lower OC alike.
Of the 759 women with a normal BMI at baseline and a valid BMI assessment in at least one of the re-examinations, 351 (46%) became overweight (obesity included) during the follow-up. There was no increase in the risk of overweight for those in the lower 25D category (crude relative risk = 1.00, 95% confidence interval 0.85-1.17) even after adjusting for confounders (relative risk = 1.00, 95% confidence interval 0.83-1.20) or stratifying by OC (data not shown).
The 25D level was not associated with height at baseline (163.4 vs 163.7 cm, P = 0.48) or at any of the re-examinations ( Figure 2 and Table 2 ).
DISCUSSION
In this study following middle-aged women into their late lives, lower 25D at baseline was associated with higher weight, BMI and WHR. These inverse associations persisted unmodified across the 32-year follow-up, also when stratified by OC. Examining the incidence of overweight and obesity in relation to 25D status strengthened our finding of no further effect of 25D on the BMI development longitudinally once the baseline difference was taken into account. In contrast to the adiposity indicators, 25D was not associated with height, either at baseline or longitudinally.
Longitudinal studies on the relationship between 25D and adiposity are few. This study is unique in its exceptionally long follow-up in relation to the baseline 25D (in serum stored for more than 3 decades vs 2 to 14-year follow-ups in the previous studies [8] [9] [10] ). Other strengths include several repeated anthropometric measurements, indicators of overall and abdominal adiposity as well as height, and high participation rate (90%) at baseline. We were able to adjust the analyses for several potential confounders, including the season of 25D measurements and time-dependent LTPA and smoking. Both OC and education were Vitamin D, adiposity and height over three decades S Lehtinen-Jacks et al considered to adjust for different aspects of socioeconomic position. 21 Furthermore, our 25D distribution-based cutoff is very close to the widely accepted level of deficiency (50 nmol/l), enabling the comparison of our results with published findings. Comparing both the lowest and highest (cutoff 89.31 nmol/l) quarters of 25D to the two middle ones (combined) confirmed our findings that 25D is not associated with subsequent widening of differences in BMI that were already present cross-sectionally.
The validity of the 25D values measured in serum samples stored for a period of 40 years has been studied previously; 19 it was found that levels were comparable with those expected in fresh blood in terms of mean, range and winter to summer variation. In the current data, four study subjects had extreme 25D values as identified by box plot analysis (197-329 nmol/l). Excluding these subjects from the analyses did not change any conclusion. However, we chose to dichotomize the 25D values in order to differentiate correctly between lower and higher values, while avoiding reliance on the absolute values.
As to limitations, higher dropout from the study was associated with higher adiposity indicators, as observed previously, 18 and with lower 25D and higher age. More of those subjects who did not participate in the re-examinations had 25D measured in early summer (the period when the mean 25D was the lowest). Together, these dropout patterns could indicate bias toward a conservative estimate of the true association between 25D and adiposity trajectory. Because this sample only had 25D values from the baseline examination, we were not able to analyze bidirectional relationships with the present design.
The evidence of an association between low 25D and increasing adiposity trajectory is sparse and mixed. The conclusion of a recent meta-analysis using a bidirectional Mendelian randomization analysis was that higher BMI seems to lead to lower 25D, whereas the opposite effect is likely to be small. 22 Our results would be consistent with this interpretation. According to recent reviews, 23, 24 vitamin D supplementation studies have yielded inconsistent results on weight and/or fat loss, in weight-loss studies and when weight loss was not planned. The general conclusion has been that supplementation does not have a substantial effect on BMI change. 23, 24 However, these conclusions could be affected by small sample size, short duration of follow-up and varying age between the studies. 23 In our separate analyses of incidence of overweight and obesity, 25D was not identified as a risk factor for either of these conditions. However, we do not know what happened before mid-life in these women: it is possible that lower 25D led to higher adiposity earlier in life 25 or that there is a vicious circle where lower 25D and higher adiposity maintain or even worsen each other. We also cannot exclude the possibility that low vitamin D and overweight have a common etiological factor, although we have excluded socioeconomic position as an explanation.
Theoretically, 25D could protect from the decline in height in older age. 11, 12 The optimal cutoff for adequate 25D is still not known, and it may vary according to the outcome: it may be that height is not affected until very low 25D values (for example, o20 nmol/l). 26 We were not able to use such a low cutoff as there were only few women in our data with such low 25D values. We are not aware of any previous longitudinal studies to compare with, but two previous studies found a positive cross-sectional association between 25D and height; nevertheless, these associations seemed to be confounded by other measures of body size. 27, 28 Vitamin D supplementation studies on bone mineral density have yielded inconsistent results, 26 ,29 and we are not aware of supplementation studies on age-related height loss. Vitamin D, adiposity and height over three decades S Lehtinen-Jacks et al Besides obesity, serum levels of 25D are associated with a broad range of lifestyle factors, such as smoking, physical activity and diet. 30 Although we have controlled for some of these factors, we cannot exclude residual confounding in the present results. However, an optimal 25D status (through healthy sun and eating habits or vitamin D supplementation) may be important for overweight women for other health-related benefits, as low 25D has been consistently associated with increased risk of cardiovascular disease, type II diabetes, some cancers and worse survival. 31, 32 In conclusion, there was no evidence for any relationship with height. The inverse association between serum 25D and weight, BMI or WHR observed at the baseline persisted but did not increase across three decades of follow-up. These results provide no evidence for the direction of causality, but for a life-long difference in adiposityrelated measures according to the 25D level in middle-aged women.
